全文获取类型
收费全文 | 1301篇 |
免费 | 106篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 8篇 |
妇产科学 | 19篇 |
基础医学 | 173篇 |
口腔科学 | 12篇 |
临床医学 | 125篇 |
内科学 | 474篇 |
皮肤病学 | 6篇 |
神经病学 | 91篇 |
特种医学 | 119篇 |
外科学 | 81篇 |
综合类 | 1篇 |
一般理论 | 1篇 |
预防医学 | 49篇 |
眼科学 | 4篇 |
药学 | 142篇 |
中国医学 | 1篇 |
肿瘤学 | 95篇 |
出版年
2024年 | 4篇 |
2023年 | 24篇 |
2022年 | 11篇 |
2021年 | 27篇 |
2020年 | 32篇 |
2019年 | 40篇 |
2018年 | 41篇 |
2017年 | 32篇 |
2016年 | 44篇 |
2015年 | 44篇 |
2014年 | 60篇 |
2013年 | 62篇 |
2012年 | 100篇 |
2011年 | 97篇 |
2010年 | 67篇 |
2009年 | 44篇 |
2008年 | 83篇 |
2007年 | 89篇 |
2006年 | 82篇 |
2005年 | 77篇 |
2004年 | 79篇 |
2003年 | 67篇 |
2002年 | 68篇 |
2001年 | 11篇 |
2000年 | 6篇 |
1999年 | 11篇 |
1998年 | 13篇 |
1997年 | 12篇 |
1996年 | 6篇 |
1995年 | 11篇 |
1994年 | 8篇 |
1993年 | 7篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 10篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1975年 | 3篇 |
1974年 | 1篇 |
1970年 | 2篇 |
排序方式: 共有1413条查询结果,搜索用时 31 毫秒
81.
J. R. J. Bänffer J. A. van Zwol-Saarloos L. J. Broere 《European journal of clinical microbiology & infectious diseases》1993,12(8):633-636
A latex agglutination test for the detection of salmonella in feces was evaluated in comparison to direct culture and enriched culture using both artificially inoculated samples and clinical samples. In the samples inoculated artificially with different concentrations of salmonella (101 to 105 per gram) the enriched culture performed better only at the 102 level in 0.4 g samples, whereas the latex test performed as well as the enriched culture at all levels in 4 g samples. In the tests using clinical samples, there was no significant difference between results of the latex test performed in 2283 samples and the enriched culture performed in 2072 samples. The sensitivity, specificity and negative and positive predictive values of the latex test were 88.2 %, 98 %, 97.5 % and 63 % respectively. The test provided results rapidly but yielded a number of false positive results. 相似文献
82.
Margreet?Lüchtenborg Matty?P?WeijenbergEmail author Petra?A?Wark A?Merdan?Saritas Guido?MJM?Roemen Goos?NP?van Muijen Adriaan?P?de Bru?ne Piet?A?van den Brandt Anton?FPM?de Goeij 《BMC cancer》2005,5(1):160
Background
The early to intermediate stages of the majority of colorectal tumours are thought to be driven by aberrations in the Wnt (APC, CTNNB1) and Ras (K-ras) pathways. A smaller proportion of cancers shows mismatch repair deficiency. The aim of this study was to analyse the co-occurrence of these genetic alterations in relation to tumour and patient characteristics. 相似文献83.
Luurtsema G Molthoff CF Schuit RC Windhorst AD Lammertsma AA Franssen EJ 《Nuclear medicine and biology》2005,32(1):87-93
There is evidence that P-glycoprotein (P-gp) in the blood-brain barrier (BBB) may be involved in the aetiology of neurological disorders. For quantification of P-gp function in vivo, (R)-[11C]verapamil can be used as a positron emission tomography (PET) tracer, provided that a mathematical model describing kinetics of uptake and clearance of verapamil is available. To develop and validate such a model, the kinetic profile and metabolism of (R)-[11C]verapamil have to be known. The aim of this study was to investigate the presence of labeled metabolites of [11C]verapamil in the plasma and (brain) tissue of Wistar rats. For this purpose, extraction and high-performance liquid chromatography (HPLC) methods were developed. The radioactive metabolites of (R)-[11C]verapamil in the liver were N-dealkylated compounds, O-demethylated compounds and a polar fraction formed from N-demethylation products of (R)-[11C]verapamil. Apart from this [11C] polar fraction, other radioactive metabolites of [11C]verapamil were not detected in the brain tissue. Thirty minutes after injection, unmetabolized (R)-[11C]verapamil accounted for 47% of radioactivity in the plasma and 69% in the brain. Sixty minutes after injection, unmetabolized (R)-[11C] verapamil was 27% and 48% in the plasma and the brain, respectively. 相似文献
84.
85.
86.
Aboosy N Mulder CJ Berends FJ Meijer JW Sorge AA 《Romanian journal of gastroenterology》2005,14(3):245-248
BACKGROUND: Small colonic lesions which are identified during endoscopy are usually difficult to locate intra-operatively. Endoscopic tattoo of the colon seems the most efficient method, however it does fail in some cases to identify the lesion peroperatively. We studied this method to evaluate its efficacy. METHODS: Nineteen patients were tattooed during colonoscopy with "India ink" (drawing ink Rotring ). These patients had lesions in which difficulties were anticipated when retracing them again during colorectal surgery. Seventeen patients underwent colonic surgery. One patient underwent laparoscopic polypectomy and the other TEM (Transanal Endoscopic Microsurgery). RESULTS: The visibility of the "India ink" peroperatively and afterwards during histological examination were evaluated. The tattoos were visible in 68.4 % patients intraoperatively. Histopathological macroscopic examination of the specimens showed ink in 73.6 % patients. In 31.5 % patients the tattoo could not be recognised peroperatively. CONCLUSIONS: Endoscopy assisted tattooing of the colon has been reported to be a safe method to landmark lesions in the colon. In the majority of our patients the tattoo was obvious during surgery. Endoscopic tattoo seems an efficient technique in identifying small colonic lesions intraoperatively. 相似文献
87.
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction 总被引:17,自引:0,他引:17
van der Meer P Lipsic E Henning RH Boddeus K van der Velden J Voors AA van Veldhuisen DJ van Gilst WH Schoemaker RG 《Journal of the American College of Cardiology》2005,46(1):125-133
OBJECTIVES: We assessed the effects of erythropoietin (EPO) treatment in a rat model of post-myocardial infarction (MI) heart failure. BACKGROUND: Erythropoietin, traditionally known as a hematopoietic hormone, has been linked to neovascularization. Whereas administration of EPO acutely after MI reduces infarct size and improves cardiac function, its role in the failing heart is unknown. METHODS: Rats underwent coronary ligation or sham surgery. Rats with MI were randomly assigned to: untreated (MI), a single bolus of EPO immediately after MI induction (MI-EPO-early), EPO treatment immediately after MI and once every three weeks (MI-EPO-early+late), and EPO treatment starting three weeks after induction of MI, once every three weeks (MI-EPO-late). After nine weeks, hemodynamics, infarct size, myosin heavy chain (MHC) isoforms, myocyte hypertrophy, and capillary density were measured. RESULTS: Erythropoietin treatment started immediately after MI (MI-EPO-early and MI-EPO-early+late) resulted in a 23% to 30% reduction in infarct size (p < 0.01) and, accordingly, hemodynamic improvement. Erythropoietin treatment, started three weeks after MI (MI-EPO-late), did not affect infarct size, but resulted in an improved cardiac performance, reflected by a 34% reduction in left ventricular end-diastolic pressure (p < 0.01), and 46% decrease in atrial natriuretic peptide levels (p < 0.05). The improved cardiac function was accompanied by an increased capillary density (p < 0.01), an increased capillary-to-myocyte ratio (p < 0.05), and a partial reversal of beta-MHC (p < 0.05) in all treated groups. CONCLUSIONS: In addition to its effect on infarct size reduction, EPO treatment improves cardiac function in a rat model of post-MI heart failure. This observation may be explained by neovascularization, associated with an increased alpha-MHC expression. 相似文献
88.
89.
90.
Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent 总被引:4,自引:0,他引:4
Gosens R Schaafsma D Grootte Bromhaar MM Vrugt B Zaagsma J Meurs H Nelemans SA 《European journal of pharmacology》2004,494(1):73-76
Growth factors have been implicated in the pathophysiology of asthma. However, the putative effects of these growth factors on human airway smooth muscle tone are still largely unknown. We performed contraction experiments using human bronchial smooth muscle ring preparations. The growth factor insulin-like growth factor-1 (IGF-1) induced a slowly developing sustained contraction, which was dependent on Rho-kinase, since contraction was almost completely inhibited by (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexane carboxamide (Y-27632; 1 microM). Angiotensin II, a G(q)-coupled receptor agonist which can act as a growth factor as well, induced a biphasic contraction, the sustained phase of which was also almost completely inhibited by Y-27632. We conclude that angiotensin II and IGF-1 induce a Rho-kinase-dependent sustained contraction of human bronchial smooth muscle. Since growth factors are associated with pathophysiological conditions such as asthma, inhibition of Rho-kinase could be effective under these conditions. 相似文献